Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Gout”

16 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 16 results

Not applicableStudy completedNCT01466166
What this trial is testing

Observational Study of the Use of Pegloticase (KRYSTEXXA®) in Refractory Chronic Gout

Who this might be right for
Refractory Chronic Gout
Horizon Pharma Rheumatology LLC 188
Testing effectiveness (Phase 2)Study completedNCT02598596
What this trial is testing

Tolerization Reduces Intolerance to Pegloticase and Prolongs the Urate Lowering Effect

Who this might be right for
Gout
Ampel BioSolutions, LLC 132
Post-approval studies (Phase 4)Study completedNCT06229145
What this trial is testing

A Trial to Investigate the Non-inferiority of Pegloticase Administered Every 4 Weeks (Q4W) With MTX Compared With Every 2 Weeks (Q2W) With MTX in Participants With Uncontrolled Refractory Gout

Who this might be right for
Gout
Amgen 262
Testing effectiveness (Phase 2)Study completedNCT00111657
What this trial is testing

Pegylated Recombinant Mammalian Uricase (PEG-uricase) as Treatment for Refractory Gout

Who this might be right for
Gout
John Sundy 30
Early research (Phase 1)Not Yet RecruitingNCT07587684
What this trial is testing

IN026 in Participants With Refractory Gout

Who this might be right for
Refractory Gout
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 16
Large-scale testing (Phase 3)Study completedNCT04596540
What this trial is testing

SEL-212 in Patients With Gout Refractory to Conventional Therapy II

Who this might be right for
Chronic Gout
Swedish Orphan Biovitrum 153
Testing effectiveness (Phase 2)Active Not RecruitingNCT07116746
What this trial is testing

Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed Patients

Who this might be right for
GoutGouty ArthritisHyperuricemia+4 more
Arthrosi Therapeutics 15
Not applicableUnknownNCT04808856
What this trial is testing

Treatment of Refractory Gout With ACTH or Methylprednisolone

Who this might be right for
Gout
Shanghai 10th People's Hospital 60
Testing effectiveness (Phase 2)Study completedNCT00080210
What this trial is testing

Persons With Gout Who Do Not Respond to or Are Allergic to Conventional Therapy

Who this might be right for
Gout
Savient Pharmaceuticals 40
Large-scale testing (Phase 3)Study completedNCT04513366
What this trial is testing

SEL-212 in Patients With Gout Refractory to Conventional Therapy

Who this might be right for
Chronic Gout
Swedish Orphan Biovitrum 112
Testing effectiveness (Phase 2)Study completedNCT03905512
What this trial is testing

Compare the Efficacy of SEL-212 to KRYSTEXXA® in Gout Participants Refractory to Conventional Therapy

Who this might be right for
Chronic Gout
Selecta Biosciences, Inc. 170
Very early researchUnknownNCT05800041
What this trial is testing

A Exploratory Trial of WTX221 in Refractory Gout Patients

Who this might be right for
Gout Tophus
RenJi Hospital 7
Testing effectiveness (Phase 2)Study completedNCT00798369
What this trial is testing

Targeted Dose Finding of Canakinumab (ACZ885) for Management of Acute Flare in Refractory or Contraindicated Gout Patients

Who this might be right for
Acute Gout
Novartis 200
Large-scale testing (Phase 3)Study completedNCT00675103
What this trial is testing

Re-exposure Study of Pegloticase Intravenous (i.v.) in Symptomatic Gout Patients

Who this might be right for
Chronic Gout Refractory to Conventional Therapy
Savient Pharmaceuticals 7
Post-approval studies (Phase 4)Study completedNCT04762498
What this trial is testing

A Phase 4, Open-label Study of KRYSTEXXA® (Pegloticase) Co-administered With Methotrexate (MTX) in Patients With Uncontrolled Gout (FORWARD OL)

Who this might be right for
Uncontrolled GoutChronic Gout
Amgen 54
Not applicableNot Yet RecruitingNCT06653686
What this trial is testing

Study on the Efficacy and Safety of Thermotherapy in the Treatment of Refractory Gout

Who this might be right for
Refractory Gout
The First Hospital of Jilin University 128